Venous thromboembolism: A clinician update

Venous thromboembolism (VTE) is a common vascular condition. New medications are available to prevent hospital-associated VTE. Strategies are being studied to increase appropriate diagnostic testing utilization. Management of deep vein thrombosis (DVT) and pulmonary embolism (PE) has evolved with th...

Full description

Saved in:
Bibliographic Details
Published in:Vascular medicine (London, England) England), 2019-04, Vol.24 (2), p.122-131
Main Authors: Serhal, Maya, Barnes, Geoffrey D
Format: Article
Language:English
Subjects:
Anticoagulants
Anticoagulants - administration & dosage
Anticoagulants - adverse effects
Catheters
Clinical Decision-Making
Diagnostic systems
Embolism
Fibrinolytic Agents - administration & dosage
Fibrinolytic Agents - adverse effects
Health risk assessment
Hemorrhage - chemically induced
Humans
Management
Medical instruments
Patient Selection
Prediction models
Pulmonary embolisms
Recurrence
Risk Assessment
Risk Factors
Thromboembolism
Thrombolytic Therapy - adverse effects
Thrombolytic Therapy - methods
Thrombosis
Time Factors
Treatment Outcome
Venous Thromboembolism - blood
Venous Thromboembolism - diagnosis
Venous Thromboembolism - drug therapy
Venous Thromboembolism - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Venous thromboembolism (VTE) is a common vascular condition. New medications are available to prevent hospital-associated VTE. Strategies are being studied to increase appropriate diagnostic testing utilization. Management of deep vein thrombosis (DVT) and pulmonary embolism (PE) has evolved with the advent of new anticoagulant options and catheter-directed intervention. In light of this, providers are commonly challenged with the decision regarding inpatient versus outpatient management. Which patients require long-term (> 3 months) anticoagulation is challenging and multiple clinical prediction models may be used to help determine the risk–benefit ratio in each patient. The management of VTE is an ongoing area of research and is rapidly evolving.
ISSN:1358-863X
1477-0377
DOI:10.1177/1358863X18821159